BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 19120853)

  • 1. Novel therapeutic endoscope facilitates endoscopic submucosal dissection of adenocarcinoma at the esophagogastric junction.
    Morioka K; Takatori Y; Masunaga T; Yahagi N; Kanai T; Kato M
    Endoscopy; 2024 Dec; 56(S 01):E470-E471. PubMed ID: 38838727
    [No Abstract]   [Full Text] [Related]  

  • 2. Her2 low (but not negative): the newest biomarker on the block for gastro-oesophageal adenocarcinoma.
    Hechtman JF
    J Clin Pathol; 2023 Dec; 76(12):813-814. PubMed ID: 37679032
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical presentation in adolescence of a gastroesophageal junction adenocarcinoma.
    Amaya Villagrán G; Loya Lazcano KM; Baeza Zapata AA
    Rev Gastroenterol Mex (Engl Ed); 2023; 88(3):299-301. PubMed ID: 37208211
    [No Abstract]   [Full Text] [Related]  

  • 4. Common metabolite for microangiopathy in Japanese and European populations.
    Shojima N; Yamauchi T
    J Diabetes Investig; 2024 May; 15(5):523-524. PubMed ID: 38517118
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastric Cancer and Its Precursor Lesions: Unraveling the Diversity in Asian Risk Profiles.
    Genta RM; Singhal A; Choi C; Turner KO
    Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1151-1156. PubMed ID: 38797533
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adenocarcinoma arising in gastroesophageal junction: a reappraisal].
    Zhang XH
    Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):363-5. PubMed ID: 17822618
    [No Abstract]   [Full Text] [Related]  

  • 7. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan.
    Kusano C; Gotoda T; Khor CJ; Katai H; Kato H; Taniguchi H; Shimoda T
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1662-5. PubMed ID: 19120859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer.
    Siewert JR; Feith M
    J Am Coll Surg; 2007 Oct; 205(4 Suppl):S49-53. PubMed ID: 17916519
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adenocarcinoma of the gastro-esophageal junction].
    Huang Q; Fan XS; Shi J; Zhang YF; Feng AN; Wu HY; Sun Q; Zhou Q; Yu HP; Meng FQ; Wang JM
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):793-5. PubMed ID: 23324225
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment procedures for adenocarcinoma of the esophagogastric junction].
    Moesta KT; Hünerbein M; Schlag PM
    Chirurg; 2003 Apr; 74(4):381-92; quiz 392-3. PubMed ID: 12719881
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges in the treatment of gastroesophageal junction cancer.
    Liakakos T
    World J Surg; 2011 Jun; 35(6):1409-10; author reply 1411. PubMed ID: 21301836
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenocarcinoma of the esophagogastric junction: do we see more or less?
    Yee YK; Wong BC
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1627-8. PubMed ID: 19120853
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical classification systems of adenocarcinoma of the esophagogastric junction.
    Mönig SP; Hölscher AH
    Recent Results Cancer Res; 2010; 182():19-28. PubMed ID: 20676868
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.